To evaluate the clinical effectiveness and cost-effectiveness of meniscal allograft transplantation (MAT) following meniscectomy, particularly in relation to the risk of osteoarthritis (OA) and its long-term implications.
Key Findings:
Meniscectomy leads to a higher prevalence of OA, with studies showing OA in 87% of meniscectomised knees versus 18% in non-operated knees, indicating a significant long-term risk.
The risk of OA increases over time, with significant degeneration observed in meniscectomised knees after 20-40 years, underscoring the need for monitoring.
Contralateral knees may not serve as ideal controls due to their own increased OA risk, complicating the assessment of meniscectomy's impact.
Interpretation:
Meniscectomy significantly increases the risk of OA, and while MAT may alleviate symptoms, its long-term chondroprotective benefits remain uncertain, warranting further research.
Limitations:
Lack of randomized controlled trials comparing MAT with conservative care limits the strength of conclusions.
Variability in study designs and definitions of OA complicates comparisons and may affect the reliability of findings.
Conclusion:
Meniscal allograft transplantation may improve symptoms, but further research is needed to clarify its role in preventing OA post-meniscectomy, particularly through well-designed RCTs.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
